X-149498308-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000202.8(IDS):c.508-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000202.8 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 2Inheritance: XL, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, PanelApp Australia, Myriad Women’s Health
- mucopolysaccharidosis type 2, attenuated formInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- mucopolysaccharidosis type 2, severe formInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IDS | NM_000202.8 | c.508-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 8 | ENST00000340855.11 | NP_000193.1 | ||
| IDS | NM_001166550.4 | c.238-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 8 | NP_001160022.1 | |||
| IDS | NM_006123.5 | c.508-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 7 | NP_006114.1 | |||
| IDS | NR_104128.2 | n.677-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 8 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IDS | ENST00000340855.11 | c.508-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 8 | 1 | NM_000202.8 | ENSP00000339801.6 | |||
| ENSG00000241489 | ENST00000651111.1 | c.-126-1G>A | splice_acceptor_variant, intron_variant | Intron 9 of 13 | ENSP00000498395.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-II Pathogenic:4
- -
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 221220). Disruption of this splice site has been observed in individuals with IDS-related conditions (PMID: 26762690, 27896113). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 4 of the IDS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in IDS are known to be pathogenic (PMID: 8940265, 9875019). -
Null variant (PVS1_Strong), De novo (PS2_Strong), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at